Skip to the page

Data / Drug companies / Lilly Del Caribe, Inc.

Lilly Del Caribe, Inc.: 52 products in the FDA NDC directory, labeler code 0110

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Lilly Del Caribe, Inc. (labeler code 0110) lists 52 products in the FDA National Drug Code Directory. By type: 50 drugs for further processing, 2 bulk ingredients. Its main marketing category is drugs for further processing. The newest product started marketing on November 25, 2025.

The request: Watch Lilly Del Caribe, Inc. (FDA labeler code 0110): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
0110
Products in commercial distribution
52
Packages
54
Finished drugs by generic name
0
Prescription products
0
Over the counter products
0
Controlled substance products
Schedule V 2
Started marketing in the last 12 months
4
Products with a marketing end date set
13
Earliest marketing start
January 6, 1998
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Drugs for further processing5096.2%
Bulk ingredients23.8%

Products by type

TypeProductsShare
Drugs for further processing5096.2%
Bulk ingredients23.8%

Dosage forms

Dosage formProductsShare
Capsule1834.6%
Tablet, film coated1325%
Tablet815.4%
Capsule, delayed release713.5%
Tablet, coated47.7%
Crystal23.8%

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Orforglipron0110-0700CapsuleDrugs for further processingNovember 25, 2025
Orforglipron0110-1230CapsuleDrugs for further processingNovember 22, 2025
Orforglipron0110-1080CapsuleDrugs for further processingNovember 20, 2025
Orforglipron0110-1520CapsuleDrugs for further processingNovember 12, 2025
Orforglipron0110-0248CapsuleDrugs for further processingNovember 6, 2025
Orforglipron0110-1625CapsuleDrugs for further processingNovember 4, 2025
Orforglipron0110-4803Tablet, film coatedDrugs for further processingOctober 17, 2025
Orforglipron0110-4839Tablet, film coatedDrugs for further processingOctober 15, 2025
Orforglipron0110-4953Tablet, film coatedDrugs for further processingOctober 5, 2025
Orforglipron0110-4794Tablet, film coatedDrugs for further processingOctober 4, 2025
Orforglipron0110-4178Tablet, film coatedDrugs for further processingOctober 2, 2025
Orforglipron0110-4503Tablet, film coatedDrugs for further processingSeptember 30, 2025
Selpercatinib0110-6120Tablet, coatedDrugs for further processingApril 10, 2024
Selpercatinib0110-6082Tablet, coatedDrugs for further processingApril 10, 2024
Selpercatinib0110-5562Tablet, coatedDrugs for further processingApril 10, 2024
Selpercatinib0110-5340Tablet, coatedDrugs for further processingApril 10, 2024
Selpercatinib0110-3977CapsuleDrugs for further processingApril 1, 2021
Selpercatinib0110-2980CapsuleDrugs for further processingApril 1, 2021
Lasmiditan0110-4491TabletDrugs for further processingOctober 11, 2019
Lasmiditan0110-4312TabletDrugs for further processingOctober 11, 2019
Insulin lispro0110-0571CrystalBulk ingredientsMarch 21, 2019
Baricitinib0110-4732Tablet, film coatedDrugs for further processingJanuary 10, 2019
Abemaciclib0110-6216TabletDrugs for further processingSeptember 28, 2017
Abemaciclib0110-5337TabletDrugs for further processingSeptember 28, 2017
Abemaciclib0110-4815TabletDrugs for further processingSeptember 28, 2017

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.